Inside Racura Oncology: Strategy, clinical milestones, and the year ahead
It's been a huge year for Racura Oncology, and CY26 only promises to get bigger as the biotech developer leaves behind its "Race" name.
The Watchlist
EVR
EV RESOURCES LTD
Mike Brown, MD & CEO
Mike Brown
MD & CEO
SPONSORED BY The Market Online
ASX News